Fosamax litigation ready for next step in bellwether cases 
By:
Correy Stephenson
Published: December 4, 2012
Tags: drug litigation, femur fracture, Fosamax, Merck, multidistrict litigation, osteonecrosis
Six years after the first Fosamax lawsuit was filed, litigation over the osteoporosis drug is about to start a new chapter.
The suits against Merck, the drug’s manufacturer, fall into two categories: plaintiffs alleging they suffer from osteonecrosis, or jaw damage, and those claiming they suffered a non-traumatic femur fracture as a result of taking the drug.
